Abivax Announces Pricing of Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares
Abivax priced an upsized $800M public offering of 6.4 million American Depositary Shares at $125.00 per ADS, representing a 2.39% premium to the three-day VWAP. Net proceeds are expected to extend the company's cash runway into the second quarter of 2029, funding the potential commercialization of obefazimod and continued clinical development.
Key figures
- Deal Value Usd
- 800000000
- Offering Price
- 125
- Shares Offered
- 6400000
- Dilution
- 8.0%
- Cash runway
- Q2 2029
- Premium to vwap
- 2.39%
- Underwriters option
- 960,000 shares
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.